BioHit 15-Minute COVID-19 Serology Antibody Test


Our Strategy to Implement COVID-19 Testing

Patient Testing:  Incorporating COVID-19 screening into patient onboarding process using rapid response antibody tests is a crucial first line of defense for screening patients prior to any hospital procedure. Instead of waiting for testing to be done in a lab, point of care facilities can be more proactive in protecting hospital employees and other patients prior to any procedure.

Business Openings: Rapid response antibody screening tests are a crucial first line of defense for screening employees that are safe to work and those fall short. Instead of waiting for testing to be done in a lab, business owners can be more proactive in protecting their employees and their customers with our tests.

School Openings: COVID-19 testing is critical for parents, students, and teachers to know if those attending class in-person are COVID-19 free.  Repeat testing will establish health security for all in the educational environment, providing added peace-of-mind that the school environment remains safe.

Track & Trace:  We have developed an application (App) allowing businesses to not only test for better safety, but also allow the business to make data driven decisions for HR/Opening/Closing by having real time optics into who is available to safely work and where there may be potential issues through identifying hotspots and locations with higher number of cases. Businesses who screen now can aid in the detection and tracking of how the virus is spreading.

How it works is offering the COVID-19 blood serum rapid test system developed by Biohit Healthcare (Hefei) Co. Ltd. distributed through the TeleMD program.  While the BioHit Healthcare (Hefei) Co., Ltd. blood serum COVID-19 test was developed in China, it is manufactured in the United States.  In offering TeleMD, including the BioHit COVID-19 blood serum test featured on this page, is a marketing affiliate of the SpeakWithAnMD TeleMD program.
BioHit Healthcare (Hefei) Co. Ltd. has received an FDA Emergency Use Authorization (EUA) for the COVID-19 test being offered by the TeleMD program.  You can read the EUA at the end of this webpage (scroll down).
BioHit Healthcare (Hefei) Co. Ltd’s COVID-19 test is described by the FDA as a Diagnostic Kit for Antibody IgM/IgG of SARS-CoV-2.  The TeleMD program requires the COVID-19 test kits must be ordered through a TeleMD consultation.  After the TeleMD prescribes a COVID-19 test, the test kit will be delivered to a participating pharmacy. All testing will be administered by trained medical professionals.  When the test is complete, the trained medical professional administering the COVID-19 test will enter the results of the test into the national NIH/CDC database accessed via the FMS Global Services proprietary software.
The COVID-19 test is a blood serum test that involves a finger-prick to draw a small sample of blood.  Test results generally take 10-15 minutes.  The tracking software involves an automated process contact tracing in positive cases and streamlines plasma donations by recovered patients.  The software is privacy enabled and HIPAA compliant.

How the BioHit 15-Minute COVID-19 Serology Antibody Test Kit Works
Watch the Video Below


The BioHit 15-Minute COVID-19 Serology Antibody Test Kit is NOT a Home Test Kit, but must be prescribed by a TeleMD physician to be delivered through a pharmacy and administered by a trained health professional.

How the COVID-19 Track & Trace Software Works
Watch the Video Below


All patient information is maintained solely by in accordance with all HIPAA privacy rules as set by U.S. laws and government regulations. Patient privacy information is not shared with

 COVID-19 Rapid Test Kit and Track & Trace Software

An easy way to find out if you have COVID-19 without leaving the safety of your own home using a simple test you do yourself

Technical Information on the Biohit Healthcare (Hefei) Co. Ltd. COVID-19 Rapid Test Kit

Serology Test Evaluation Report
FDA Emergency Use Authorization

You can read each full report by clicking on each first page above.

“My Ph.D. is in political science from Harvard University in 1972. I am not a medical doctor and I do not give medical advice. On, all medical advice will be from qualified licensed physicians participating with” – Jerome R. Corsi, Ph.D.